MedTrace Logo

A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

NCT02950012 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-10-29

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of OPTI-BIOME™ (Bacillus subtilis MB40), a probiotic supplement, on bloating, gas and abdominal discomfort symptoms in otherwise healthy adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

OPTI-BIOME™ Bacillus subtilis MB40

OTHER

Placebo

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • BIO-CAT Microbials, LLC

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD' · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950012 on ClinicalTrials.gov